Regonol (Sandoz Inc)
Welcome to the PulseAid listing for the Regonol drug offered from Sandoz Inc. This Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Sandoz Inc |
NON-PROPRIETARY NAME: | Pyridostigmine Bromide |
SUBSTANCE NAME: | PYRIDOSTIGMINE BROMIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] |
ROUTE: | INTRAVENOUS; PARENTERAL |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2005-05-10 |
END MARKETING DATE: | 0000-00-00 |
Regonol HUMAN PRESCRIPTION DRUG Details:
Item Description | Regonol from Sandoz Inc |
LABELER NAME: | Sandoz Inc |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 5(mg/mL) |
START MARKETING DATE: | 2005-05-10 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0781-3040_44da988e-5709-4647-a578-ad7935601c7e |
PRODUCT NDC: | 0781-3040 |
APPLICATION NUMBER: | NDA017398 |
Other PYRIDOSTIGMINE BROMIDE Pharmaceutical Manufacturers / Labelers: